Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

IDEAYA Biosciences, Inc. (IDYA)

8-K Other material confidence 75% filed 2026-06-01 Item 8.01

IDEAYA disclosed complete Phase 2/3 trial data for darovasertib combination in metastatic uveal melanoma, meeting the primary endpoint with statistically significant PFS improvement (6.9 vs 3.1 months, p<0.0001) and favorable secondary endpoints, representing a significant clinical milestone supporting anticipated NDA filing.

View raw filing on EDGAR →

GENCOR INDUSTRIES INC (GENC)

8-K Delisting risk confidence 98% filed 2026-06-01 Item 3.01

GENCOR Industries received a formal Delinquency Notification from NYSE Regulation on May 19, 2026, for non-compliance with NYSE American continued listing standards due to failure to timely file its Form 10-Q. The company has a six-month cure period, and NYSE may commence suspension and delisting proceedings at any time.

View raw filing on EDGAR →

BOSTON BEER CO INC (SAM)

8-K Material Litigation confidence 95% filed 2026-06-01 Item 8.01

The filing discloses a jury verdict and amended final judgment in a supplier dispute with Ardagh Metal Packaging USA Corp., resulting in damages of $175.5 million plus $15.5 million in pre-judgment interest (combined $191.0 million pre-tax total). This material litigation event, involving a substantial financial judgment against the Company, would significantly affect a reasonable investor's assessment of Boston Beer's financial position and liabilities. The Company intends to pursue appellate remedies, indicating ongoing litigation exposure.

View raw filing on EDGAR →

BOSTON BEER CO INC (SAM)

8-K Shareholder vote confidence 95% filed 2026-06-01 Item 5.01

Results of the 2026 Annual Meeting of Stockholders held on May 27, 2026, including voting outcomes on director elections (Class A and Class B), an advisory vote on executive compensation, and ratification of the independent auditor.

View raw filing on EDGAR →

Repay Holdings Corp (RPAY)

8-K M&A activity confidence 97% filed 2026-06-01 Item 2.01

Repay Holdings completed the acquisition of KUBRA Holdings, Inc. and KUBRA Data Transfer Ltd. for approximately $372 million in cash, funded by a new $500M term loan facility and $100M revolving credit facility, plus cash on hand. The acquisition was financed through entry into a new Credit Agreement and termination of the prior revolving credit facility.

View raw filing on EDGAR →

CVB FINANCIAL CORP (CVBF)

8-K Exec Compensation confidence 95% filed 2026-06-01 Item 5.02

The disclosure centers on a Third Amended and Restated Employment Agreement with David A. Brager, the CEO, executed on June 1, 2026. The filing details comprehensive compensatory arrangements including base salary ($966,000), annual bonus targets (120% of base, max 180%), equity grants (180% target, 150% minimum of base salary annually), severance provisions (2x base plus 2x average bonus; 2.5x in change-of-control scenarios), and perquisites (automobile allowance, club memberships). This is a material renewal and extension of executive compensation terms through June 30, 2029, directly falling under Item 5.02(e) disclosure of compensatory arrangements.

View raw filing on EDGAR →

Penguin Solutions, Inc. (PENG)

8-K Exec appointment confidence 85% filed 2026-06-01 Item 5.02

Aaron Johnson was appointed as interim CFO and principal financial and accounting officer of Penguin Solutions, Inc., effective July 9, 2026, succeeding Nate Olmstead who resigned from the CFO position effective July 8, 2026.

View raw filing on EDGAR →

NORTHERN OIL & GAS, INC. (NOG)

8-K M&A activity confidence 85% filed 2026-06-01 Item 1.01

Northern Oil & Gas entered into a material definitive agreement involving a Purchase and Sale Agreement with ancillary Registration Rights Agreement, whereby the Company acquired assets or a business and issued equity securities (Stock Consideration) to the seller as part of the transaction.

View raw filing on EDGAR →

Leslie's, Inc. (LESL)

8-K Delisting risk confidence 95% filed 2026-06-01 Item 8.01

Leslie's received a Nasdaq delisting notice on February 11, 2026 for failing to maintain the minimum market value of publicly held shares ($15 million) for 30 consecutive business days under Listing Rule 5450(b)(3)(C), with an August 10, 2026 compliance deadline. The May 29, 2026 letter confirms the Company has regained compliance and the matter is closed. This disclosure directly addresses a delisting risk event and its resolution, which is material to investors assessing the registrant's continued listing status.

View raw filing on EDGAR →

VERRA MOBILITY Corp (VRRM)

8-K Exec appointment confidence 90% filed 2026-06-01 Item 5.02

Jonathan Keyser was appointed as Interim President and Chief Executive Officer of Verra Mobility Corp effective May 31, 2026, as disclosed via press release on June 1, 2026. This represents a material change in the Company's chief executive leadership.

View raw filing on EDGAR →

COMMUNITY HEALTH SYSTEMS INC (CYH)

8-K M&A activity confidence 98% filed 2026-06-01 Item 2.01

Community Health Systems completed the disposition of substantially all assets of four hospital facilities in Arkansas (Northwest Medical Center locations and Siloam Springs Regional Hospital) plus associated outpatient centers to Freeman Health System for $110 million in cash. The transaction was explicitly identified as a significant disposition under Item 2.01 of Form 8-K.

View raw filing on EDGAR →

AVIS BUDGET GROUP, INC. (CAR)

8-K Other material confidence 75% filed 2026-06-01 Item 8.01

Avis Budget issued $300 million in 8.000% Senior Notes due 2031 on May 29, 2026, intending to use proceeds to redeem a portion of its 5.750% Senior Notes due 2027. While this is a material debt issuance and refinancing activity affecting the company's capital structure and financial obligations, it does not fit cleanly into the more specific event categories (ma_activity applies to acquisitions/dispositions, not debt issuances; covenant_breach requires a violation). The disclosure is material to investors as it affects leverage, interest expense, and debt maturity profile, but the primary action is a routine debt offering and refinancing rather than a discrete material event like M&A, impairment, or covenant breach.

View raw filing on EDGAR →

Seres Therapeutics, Inc. (MCRB)

8-K Exec departure confidence 95% filed 2026-06-01 Item 5.02

Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a board member of Seres Therapeutics effective May 31, 2026. The disclosure explicitly states the departure and its effective date, with a standard representation that the resignation was not due to disagreement. Board departures are material events affecting the composition of the company's governance.

View raw filing on EDGAR →

BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM)

8-K M&A activity confidence 75% filed 2026-06-01 Item 1.01

Bright Horizons entered into a Fifth Amendment to its credit agreement on June 1, 2026, providing $375 million in incremental term A loans and increasing the revolving credit facility from $900 million to $1,000 million. This material capital structure event expands total available liquidity and restructures existing debt obligations.

View raw filing on EDGAR →

Callaway Golf Co (CALY)

8-K Other material confidence 72% filed 2026-06-01 Item 7.01

Callaway Golf announced full repayment of its Term Loan B, a material debt reduction event that improves the company's financial position and reduces leverage. While this is positive news rather than a distress signal, the complete repayment of a term loan facility is material to investors assessing the registrant's capital structure and financial health. This does not fit neatly into the more specific event categories (not a restatement, covenant breach, going concern, or impairment), making "other_material" the most appropriate classification.

View raw filing on EDGAR →

LSB INDUSTRIES, INC. (LXU)

8-K Other material confidence 72% filed 2026-06-01 Item 8.01

LSB Industries disclosed an acceleration of a previously announced turnaround at its Pryor, Oklahoma facility from July 2026 to immediate commencement on May 28, 2026. While the company states the change in timing should not affect expected duration or cost estimates, the acceleration of a major capital project affecting production capacity and customer commitments is material to investors assessing operational risk and near-term financial performance. This does not fit neatly into the more specific event categories (not M&A, impairment, covenant breach, or litigation), making "other_material" the appropriate classification.

View raw filing on EDGAR →

Jefferies Credit Partners BDC Inc.

8-K Dilutive issuance confidence 95% filed 2026-06-01 Item 3.02

The filing discloses an unregistered sale of 622,093.540 shares of Class I common stock for approximately $8.9 million, exempt under Section 4(a)(2) and Regulation D. This is a classic dilutive equity issuance by a BDC raising capital through a private placement, which materially affects shareholder ownership and the company's capital structure.

View raw filing on EDGAR →

MEDICAL PROPERTIES TRUST INC (MPT)

8-K Shareholder vote confidence 98% filed 2026-06-01 Item 5.07

This is a clear disclosure of shareholder voting results from Medical Properties Trust's annual meeting held on May 28, 2026. The filing presents final vote tallies for four proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as auditor, advisory vote on executive compensation, and approval of the Second Amended and Restated 2019 Equity Incentive Plan. This is a quintessential Item 5.07 disclosure and is material as it documents the outcomes of fundamental corporate governance matters.

View raw filing on EDGAR →

Aeva Technologies, Inc. (AEVA)

8-K Exec Compensation confidence 95% filed 2026-06-01 Item 5.02

The Compensation Committee approved cash bonuses for three named executive officers (Soroush Salehian Dardashti, Mina Rezk, and Saurabh Sinha) for 2025 service. This is a compensatory arrangement disclosure under Item 5.02(f), specifically the determination and approval of performance-based cash bonuses tied to employment agreements. The filing explicitly notes the Committee's approval of bonus amounts that were not determined at the time of the proxy statement filing, making this a material disclosure of executive compensation.

View raw filing on EDGAR →

CORVEL CORP (CRVL)

8-K Exec appointment confidence 92% filed 2026-06-01 Item 5.02

Sarah Scott was appointed Chief Executive Officer and President of CorVel Corporation, effective July 1, 2026, with detailed compensation arrangements including a base salary of $600,000, bonus targets, and stock option grants, following Michael G. Combs' transition to Executive Chair.

View raw filing on EDGAR →

Seritage Growth Properties (SRG-PA)

8-K M&A activity confidence 92% filed 2026-06-01 Item 1.01

The filing discloses entry into a material option purchase and sale agreement for the sale of a Dallas, Texas property for $50.76 million, with closing contingent on entitlements and other conditions through January 2028. This constitutes a material disposition transaction under Item 1.01, as the sale price and asset value are substantial relative to a REIT's portfolio. The cross-conditioning with an adjacent property agreement and the extended option period with monthly payments ($126,900–$274,950) indicate a complex, material real estate transaction that would affect investor assessment of the company's asset base and liquidity.

View raw filing on EDGAR →

PennantPark Floating Rate Capital Ltd. (PFLT)

8-K M&A activity confidence 75% filed 2026-06-01 Item 1.01

PennantPark entered into a Third Supplemental Indenture on June 1, 2026, relating to the issuance of $105 million in aggregate principal amount of 7.375% Notes due 2031. While this is technically a debt issuance rather than a traditional M&A transaction, the Item 1.01 classification and the materiality of the $101.19 million net proceeds (to be used for repaying credit facilities, investing in portfolio companies, and general corporate purposes) indicate a material capital-raising event that affects the company's financial structure and strategic direction.

View raw filing on EDGAR →

Nuburu, Inc. (BURUW)

8-K M&A activity confidence 95% filed 2026-06-01 Item 1.01

This disclosure describes Nuburu's entry into a material definitive agreement to acquire a 70% equity interest in Tekne S.p.A. through a combination of capital contributions (€17.692 million to date, up to $12 million additional), a subscription for 57.1% of shares (€29.692 million), and a stock purchase of 10% for €5.2 million plus earn-out payments up to €29.692 million through 2036. The transaction is contingent on Italian government Golden Power approval by September 30, 2026, and represents a significant acquisition activity that would materially affect the registrant's financial position and strategic direction.

View raw filing on EDGAR →

ENVIRI Corp (NVRI)

8-K M&A activity confidence 97% filed 2026-06-01 Item 2.01

Enviri completed a complex multi-step transaction involving a holding company merger converting Enviri shareholders into CLEH shareholders, a distribution of New Enviri shares, and a merger of CLEH into a Veolia subsidiary for $3.04 billion in aggregate consideration ($15.00 per share in cash), resulting in Veolia acquiring the Clean Earth Business and a change of control of Enviri.

View raw filing on EDGAR →

Enviri II Corp

8-K M&A activity confidence 93% filed 2026-06-01 Item 1.01

Enviri II Corp completed a holding company merger and spin-off transaction on June 1, 2026, whereby Enviri stockholders received CLEH Common Stock in the merger and subsequently New Enviri Common Stock in a distribution, resulting in New Enviri becoming a separate publicly traded company. This material change of control and reorganization involved the separation and distribution of a subsidiary with significant impact on the registrant's ownership structure and control.

View raw filing on EDGAR →

Enviri II Corp

8-K M&A activity confidence 72% filed 2026-06-01 Item 2.03

In connection with the spin-off transaction, the registrant created direct financial obligations via Senior Secured Credit Facilities, which were arranged as part of the material transaction.

View raw filing on EDGAR →

Enviri II Corp

8-K Exec Compensation confidence 92% filed 2026-06-01 Item 5.02

The registrant adopted the Enviri II Corporation 2026 Omnibus Incentive Plan effective May 28, 2026, pursuant to which the CEO, CFO, and other executive officers are eligible to participate in grants of stock options, restricted awards, performance shares, and other equity-based awards.

View raw filing on EDGAR →

Enviri II Corp

8-K Other material confidence 75% filed 2026-06-01 Item 5.03

In connection with the spin-off completion, the registrant amended and restated its certificate of incorporation and bylaws, effected a stock split increasing authorized shares, and changed its name from Enviri II Corporation to Enviri Corporation, materially restructuring the post-spin entity's capital stock and governance structure.

View raw filing on EDGAR →

OCEANFIRST FINANCIAL CORP (OCFC)

8-K M&A activity confidence 95% filed 2026-06-01 Item 2.01

OceanFirst completed a merger with Flushing Bank on June 1, 2026, acquiring Flushing's assets and assuming approximately $251.9 million in subordinated and junior subordinated debt obligations. The transaction represents a significant change in OceanFirst's asset base, business composition, and capital structure.

View raw filing on EDGAR →

OCEANFIRST FINANCIAL CORP (OCFC)

8-K Dilutive issuance confidence 95% filed 2026-06-01 Item 3.02

OceanFirst issued approximately 9.5 million shares of common stock and 1.8 million shares of NVCE Stock (common-equivalent) to Warburg Pincus for $225 million, plus a warrant to purchase 11.4 million additional shares, all in reliance on Section 4(a)(2) exemption from registration. The issuance includes a Registration Rights Agreement requiring future registration of the securities.

View raw filing on EDGAR →

OCEANFIRST FINANCIAL CORP (OCFC)

8-K Other material confidence 85% filed 2026-06-01 Item 3.03

OceanFirst created a new class of preferred stock designated as NVCE Stock via Certificate of Designations filed with Delaware, establishing specific rights, preferences, and conversion terms tied to the Warburg Pincus investment and merger consummation.

View raw filing on EDGAR →

OCEANFIRST FINANCIAL CORP (OCFC)

8-K Exec appointment confidence 85% filed 2026-06-01 Item 5.02

OceanFirst appointed seven new directors effective June 1, 2026: six former Flushing Bank directors (Buran, DelliBovi, D'Iorio, Grassi, Han, Yoh) and Todd Schell designated by Warburg Pincus. John R. Buran was appointed Non-Executive Chairman, replacing Christopher D. Maher.

View raw filing on EDGAR →

FLUSHING FINANCIAL CORP (FFIC)

8-K M&A activity confidence 95% filed 2026-06-01 Item 2.01

Flushing Financial completed a material acquisition or merger transaction, with OceanFirst as the successor entity. All directors and officers of Flushing ceased serving at the effective time of the merger, and security holders' rights were materially modified, with shareholders receiving merger consideration in exchange for their shares.

View raw filing on EDGAR →

FLUSHING FINANCIAL CORP (FFIC)

8-K Delisting risk confidence 95% filed 2026-06-01 Item 3.01

Flushing Financial's common stock was suspended from trading on Nasdaq effective June 1, 2026, following notification of the merger completion. The company will be delisted from Nasdaq upon effectiveness of Form 25, and OceanFirst intends to file Form 15 to terminate registration and suspend reporting obligations.

View raw filing on EDGAR →

MERCER INTERNATIONAL INC. (MERC)

8-K Shareholder vote confidence 98% filed 2026-06-01 Item 5.07

This is a classic Item 5.07 disclosure reporting the results of Mercer International's 2026 Annual Meeting of Shareholders held on June 1, 2026. The filing presents voting tallies for three proposals: election of nine directors (all elected), advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. These are routine but material shareholder governance matters that affect investor understanding of board composition and management accountability.

View raw filing on EDGAR →

GENERATION INCOME PROPERTIES, INC. (GIPRW)

8-K Dilutive issuance confidence 92% filed 2026-06-01 Item 1.01

Generation Income Properties completed a best efforts public offering of 23.8 million shares of common stock (or pre-funded warrants) and 23.8 million warrants at $0.21 per unit, raising approximately $4.4 million in net proceeds. The offering materially increases share count and dilutes existing shareholders.

View raw filing on EDGAR →

Karman Holdings Inc. (KRMN)

8-K Dilutive issuance confidence 85% filed 2026-06-01 Item 1.01

Karman Holdings Inc. entered into an underwriting agreement on May 28, 2026 for a public offering of 14,000,000 shares of common stock at $61.00 per share, with an additional 2,100,000 shares available under a 30-day option, which closed on June 1, 2026. The Company agreed to a 90-day lock-up and provided representations and warranties in the Underwriting Agreement, indicating material involvement in the offering. This material equity issuance would significantly affect shareholder dilution and the total mix of information available to investors.

View raw filing on EDGAR →

Columbus Acquisition Corp/Cayman Islands (COLAR)

8-K Delisting risk confidence 95% filed 2026-06-01

The filing discloses Item 3.01 regarding a delisting notice from Nasdaq. Columbus Acquisition Corp received a May 22, 2026 notice that its market value of listed securities (MVLS) fell below the $50 million minimum requirement under Nasdaq Listing Rule 5450(b)(2)(A). Although the company subsequently regained compliance by May 28, 2026, the initial delisting notice and the company's prior non-compliance with continued listing standards is a material event that would affect investor assessment of listing status and trading continuity.

View raw filing on EDGAR →

Rising Dragon Acquisition Corp. (RDACU)

8-K Shareholder vote confidence 92% filed 2026-06-01

The filing's primary disclosure is Item 5.07, which reports the results of Rising Dragon's extraordinary general meeting held on May 28, 2026. The filing details three shareholder proposals with voting results: approval of a charter amendment to extend the business combination deadline by 15 months (to October 15, 2027), approval of a trust agreement amendment to fund the extension, and authorization to adjourn the meeting. All three proposals passed with substantial majorities. This is material to investors as it directly affects the company's timeline to complete a business combination and the redemption rights of shareholders.

View raw filing on EDGAR →

MoonLake Immunotherapeutics (MLTX)

8-K M&A activity confidence 85% filed 2026-06-01 Item 1.01

MoonLake entered into a Master Commercial Supply Agreement with Vetter Pharma on May 22, 2026, establishing a binding manufacturing and supply relationship for the Company's product candidates, including sonelokimab. The agreement includes capacity reservations, pricing terms, and termination provisions that create material commercial obligations. While this is a supply/manufacturing agreement rather than a traditional M&A transaction, it represents a material definitive agreement that would affect investor assessment of the Company's manufacturing strategy and operational commitments.

View raw filing on EDGAR →

Jasper Therapeutics, Inc. (JSPRW)

8-K Other material confidence 72% filed 2026-06-01 Item 7.01

The Board has initiated a "comprehensive review of strategic alternatives aimed at maximizing shareholder value," which signals potential M&A activity, restructuring, or other transformative corporate actions. While the disclosure does not confirm a specific transaction, the announcement of a formal strategic review is material to investors as it indicates the company is actively considering significant changes to its business structure or ownership. This does not fit neatly into the M&A taxonomy (which typically requires entry into, completion, or termination of a transaction) but is clearly material and warrants classification as other_material pending further developments.

View raw filing on EDGAR →

Optimum Communications, Inc. (OPTU)

8-K M&A activity confidence 78% filed 2026-06-01 Item 8.01

Unsub Topco launched a tender offer to purchase up to 120 million Class A shares of Optimum Communications at $2.50/share ($300 million aggregate), funded by proceeds from a private placement transaction, with a potential registered public exchange offer to follow. The transaction represents a material change of control activity involving significant equity restructuring and anticipated debt restructuring discussions with CSC Holdings creditors.

View raw filing on EDGAR →

Aditxt, Inc. (ADTX)

8-K Exec departure confidence 75% filed 2026-06-01 Item 5.02

Amro Albanna resigned as Chief Executive Officer and Director, Shahrokh Shabahang resigned as Director, and Rowena Albanna resigned as Chief Operating Officer. Jeffrey M. Busch was appointed as Interim CEO and Brian Brady as Chairman.

View raw filing on EDGAR →

Silo Pharma, Inc. (SILO)

8-K Other material confidence 75% filed 2026-06-01 Item 8.01

The filing discloses a 1-for-15 reverse stock split effective June 2, 2026, which materially affects the capital structure and share count (from ~16.267 million to ~1.084 million shares outstanding). While reverse splits are sometimes routine capital management actions, this event is material to investors as it affects share price, voting power, and equity award calculations. The disclosure does not fit the more specific event categories (not an earnings release, executive change, M&A, impairment, or delisting notice), making "other_material" the most appropriate classification.

View raw filing on EDGAR →

Energy Transition Special Opportunities (ETSS-UN)

8-K Other material confidence 75% filed 2026-06-01 Item 8.01

The disclosure announces the commencement of separate trading of Class A ordinary shares and Warrants previously bundled in Units, effective June 4, 2026. While this is a routine post-IPO structural event for special purpose acquisition companies (SPACs), it materially affects how investors can trade the underlying securities and represents a significant change in the capital structure's tradability. This does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A activity, or financial restatement), making "other_material" the appropriate classification.

View raw filing on EDGAR →

Revium Rx. (RVRC)

8-K Exec appointment confidence 85% filed 2026-06-01 Item 5.02

The filing discloses both a CFO departure (Arie Gordashnikov) and an appointment (Igor Bluvstein) on the same date. The principal action emphasized is the appointment of Bluvstein as CFO, with detailed background on his 17+ years of financial leadership experience across multiple public companies (Argent BioPharma, G Medical Innovations, etc.). While a departure also occurred, the appointment is the forward-looking material event that would affect investor assessment of the company's financial leadership and governance.

View raw filing on EDGAR →

ONE LIBERTY PROPERTIES INC (OLP)

8-K Earnings release confidence 85% filed 2026-06-01 Item 2.02

One Liberty Properties disclosed Q1 2026 financial results on June 1, 2026, providing key financial performance metrics and operational updates to investors.

View raw filing on EDGAR →

Oruka Therapeutics, Inc. (ORKA)

8-K Other material confidence 72% filed 2026-06-01 Item 8.01

Oruka entered into a First Amendment to its IL-23 License Agreement with Paragon Therapeutics on May 29, 2026, expanding the Field to include inflammatory bowel disease—a significant therapeutic expansion for the Company's lead candidate ORKA-001. While this is a material licensing amendment affecting the Company's development rights and commercial scope, it does not fit cleanly into the more specific event categories (not an M&A transaction, not a covenant breach, not a restatement or going-concern issue). The expansion of therapeutic indications and the conditional restrictions on dosing timelines represent a material modification to the Company's intellectual property and development strategy.

View raw filing on EDGAR →

Spectral AI, Inc. (MDAIW)

8-K Shareholder vote confidence 95% filed 2026-06-01

The 8-K discloses results of the 2026 Annual Meeting of Stockholders held on May 29, 2026, under Item 5.07. The filing reports voting outcomes for three proposals: election of five directors (DiMaio, Cotton, Mellish, Sadagopan, and Snyder), ratification of Forvis Mazars LLP as independent auditor, and approval of share issuance to Hudson Bay Master Fund Ltd. under a Securities Purchase Agreement. These shareholder votes are material to investors as they determine board composition and authorize significant equity issuances.

View raw filing on EDGAR →

Pluri Inc. (PLUR)

8-K Covenant Breach confidence 75% filed 2026-06-01 Item 8.01

The filing discloses a €20 million EIB loan that matured on June 1, 2026 (the filing date), with the company and lender engaged in discussions regarding "potential alternatives, including a possible extension of the maturity date." The EIB reserved all rights while discussions continue through July 3, 2026, and explicitly stated "no enforcement action is currently contemplated" — language indicating the loan is in technical default or at imminent risk thereof. This represents a triggering event that could accelerate a direct financial obligation and is a material indicator of financial stress, fitting the covenant_breach category.

View raw filing on EDGAR →